Optic Neuritis (cont.)
Andrew A. Dahl, MD, FACS
Andrew A. Dahl, MD, is a board-certified ophthalmologist. Dr. Dahl's educational background includes a BA with Honors and Distinction from Wesleyan University, Middletown, CT, and an MD from Cornell University, where he was selected for Alpha Omega Alpha, the national medical honor society. He had an internal medical internship at the New York Hospital/Cornell Medical Center.
William C. Shiel Jr., MD, FACP, FACR
Dr. Shiel received a Bachelor of Science degree with honors from the University of Notre Dame. There he was involved in research in radiation biology and received the Huisking Scholarship. After graduating from St. Louis University School of Medicine, he completed his Internal Medicine residency and Rheumatology fellowship at the University of California, Irvine. He is board-certified in Internal Medicine and Rheumatology.
In this Article
- Optic neuritis facts
- What is optic neuritis?
- What causes optic neuritis?
- What are optic neuritis risk factors?
- What are symptoms of optic neuritis?
- What are signs of optic neuritis?
- What types of doctors treat optic neuritis?
- How do health-care professionals diagnose optic neuritis?
- What is the treatment for optic neuritis?
- What is the prognosis for optic neuritis?
- Is it possible to prevent optic neuritis?
- Where can I find more information on optic neuritis?
- Find a local Eye Doctor in your town
What is the treatment for optic neuritis?
If a definite cause (such as infection or underlying other disease) is determined, appropriate therapy for that cause is instituted.
The Optic Neuritis Treatment Trial, a multicenter randomized trial with 15 years of follow-up, showed that oral corticosteroids (prednisone) had no benefit on recovery to normal visual acuity. High-dose intravenous steroids, which involve some risks and can have significant side effects in some patients, including elevated blood sugar, depression, and insomnia. In the trial, high-dose intravenous steroids did speed up the initial recovery of vision in the acute phase. However, there was no conclusive evidence that intravenous steroids had any long-term benefit on visual acuity, visual field, or contrast sensitivity five years later.
Although there is no evidence that the use of oral nonsteroidal anti-inflammatory drugs (NSAIDs) have an effect on ultimate visual outcomes, they are effective in decreasing the pain on eye movement often associated with optic neuritis.
Get breaking medical news.